Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions
Crossref DOI link: https://doi.org/10.1007/s11095-017-2221-4
Published Online: 2017-07-07
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Trasi, Niraj S.
Purohit, Hitesh S.
Taylor, Lynne S. http://orcid.org/0000-0002-4568-6021
Funding for this research was provided by:
U.S. Food and Drug Administration (1U01FD005259-01)
Text and Data Mining valid from 2017-07-07
Version of Record valid from 2017-07-07
Article History
Received: 12 January 2017
Accepted: 22 June 2017
First Online: 7 July 2017